James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

3 Big Stock Charts for Wednesday: Cardinal Health, Dish Network and Global Payments

The stock charts of Cardinal Health, Dish Network and Global Payments are headed into the middle of the week at make-or-break levels.

Response to Sealed Air’s Q2 (Almost) Makes SEE Stock a Top Bet

If the SEE stock price can just get over a couple of key technical hurdles, Sealed Air is one of the market's best plays in an otherwise lousy environment.

3 Big Stock Charts for Tuesday: Pfizer, AES and Centurylink

The stock charts of Pfizer, AES and Centurylink have emerged as enticing prospects within a sea of volatility.

Fear Around Bristol-Myers Squibb Stock is Starting to Fade

BMY stock may continue to bounce around, but the months-long selloff is now slowing because Bristol-Myers Squibb is still thriving.

Solar and Storage Will Eventually Be Positive for Tesla and TSLA Stock

Many owners of TSLA stock feel Elon Musk's interest in solar roofs and power-storage are a costly distraction. That could change soon.